AVIR R&D Expenses

Atea Pharmaceuticals Inc · R&D Expenses

AVIR logo

AVIR R&D Expenses

Latest reported$155.45M
AVIR R&D Expenses ($6.68M → $155.45M)
High-resolution chart · PNG

AVIR r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atea Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
148,024,000
145,401,000
132,843,000
88,836,000
167,205,000
38,023,000
10,170,000
6,675,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.